Announced Fri, 8 May · 18:06 IST

Change in Directors

Multiple Ind Directors ResignedManagement Changes View source PDF

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹81.29
prior close
₹84.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.8+4.9+3.8+3.7+2.8+1.5-1.4-1.6-1.6+0.4+3.3+1.7+8.4
Up moveDown movePending
AI summary

Niva Bupa's board saw multiple changes on May 8, 2026. Two senior Bupa executives—Mr. Christopher Patrick Carroll (CEO of Bupa Global, India & UK) and Ms. Siobhan Djihan Moynihan (CFO of Bupa Global, India & UK)—were appointed as Non-Executive Directors effective May 15, 2026, pending shareholder approval. Internally, Mr. Ankur Kharbanda was elevated from Executive Director and Chief Business Officer to Executive Director and Deputy CEO. Simultaneously, two Non-Executive Directors—Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo—resigned citing insufficient time due to other professional commitments. The company also granted 12,251,268 ESOPs at ₹72.45 per option to eligible employees.

Likely market impact

The resignation of two non-executive directors on the same day raises minor governance concerns as both cited time constraints. However, the appointment of two senior Bupa global executives (Christopher and Siobhan) appears to strengthen the board with experienced insurance leadership. The internal promotion of Ankur Kharbanda signals management continuity and succession planning.